Haemonetics Corporation (HAE)

NYSE - Nasdaq Real Time Price. Currency in USD

Add to watchlist

59.16

-0.16

(-0.27%)

As of 10:54AM EDT. Market open.

Advertisement

Loading interactive chart...

Zacks
Haemonetics (HAE) Q4 Earnings Top Estimates, Gross Margin Up
Robust performance by Plasma and Hospital businesses drove Haemonetics' (HAE) revenues in the fiscal fourth quarter.
Zacks
Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates
Haemonetics (HAE) delivered earnings and revenue surprises of 8.33% and 2.56%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
PR Newswire
Haemonetics 4th Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website
Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter fiscal 2022, which ended April 2, 2022, are available on its Investor Relations website.